Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Seminars in Oncology(2)
BJGP Open(1)
Expert Review of Respiratory Medicine(1)
Frontiers in Oncology(1)
Immune Rebalancing: The Future of Immunosuppression(1)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(5)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Problemas sociales y servicios a grupos(1)
Origen
scopus(6)
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
ArticleAbstract: Background: CIMAvax-EGF is an epidermal growth factor (EGF)-depleting immunotherapy which has shownPalabras claves:immune checkpoint inhibitor, immunotherapy, lung cancer, Non-small cell lung cancer, VaccineAutores:Attwood K., Cedeno C., Cinquino A., Dai T., Dozier A., Dy G.K., Ernstoff M., Evans R., Fisher D.T., Fountzilas C., Groman A., Hutson A., Johnson C., Lage Davila A., Lee K., Leon K., Luaces P.L.o., Mazorra Z., Mesa C., Muhitch J., Opyrchal M., Puzanov I., Reid M., Saavedra Hernández D., Santos-Morales O., Tania Crombet, Wallace P.K.Fuentes:scopusCIMAvax-EGF: Toward long-term survival of advanced NSCLC
ReviewAbstract: Lung cancer remains one of the leading causes of cancer-related deaths. Non–small cell lung cancer (Palabras claves:cancer vaccine, CIMAvax-EGF, Clinical trial, EGF, Epidermal growth factor receptor, immunotherapy, non–small cell lung cancerAutores:Camilo Rodríguez, Carmen Elena Viada, Lage Davila A., Mazorra Z., Neninger Vinageras E., Saavedra Hernández D., Tania CrombetFuentes:scopusDifferential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer
ArticleAbstract: Background: Progress in immunotherapy has revolutionized the treatment landscape for advanced lung cPalabras claves:immunotherapy, long-term survival, non–small cell lung cancer, survival mixture modelsAutores:Alfonso S., Carmen Elena Viada, Lage Davila A., Luaces P.L.o., Muchene L., Neninger Vinageras E., Rodríguez P.C., Sánchez L., Shkedy Z., Tania CrombetFuentes:scopusMulticentre oncology clinical trials in primary health care in Cuba: evaluation of programme implementation in Villa Clara Province, 2010–2020
ArticleAbstract: Background: The Center of Molecular Immunology of Cuba has developed a programme for the conductingPalabras claves:clinical trials, General practitioners, immunotherapy, neoplasms, Oncology, Primary Health Care, primary healthcareAutores:Artiles M., Cepeda M., Crespo J.C., de la Barca N.d.C., González A., Granela M.C., Lage Davila A., Lorenzo G., Marrero R., Méndez R., Nieto L., Norvel M., Ortiz R.A., Rodríguez M., Sánchez L., Tania Crombet, Toledo E., Torres O.Fuentes:scopusImmunotherapy for Transforming Advanced Cancer into a Chronic Disease: How Far Are We?
Book PartAbstract: For chronic diseases medical success does not mean cure, but long-term control, improved quality ofPalabras claves:antibody, Cáncer, Cancer Vaccines, Chronicity, Clinical trial, immunotherapyAutores:Lage Davila A., Tania CrombetFuentes:scopusTherapeutic vaccination with an EGF-based vaccine in lung cancer: A step in the transition to a chronic disease
ArticleAbstract: The trend of increased survival in advanced tumors suggests the possibility of the transformation ofPalabras claves:cancer vaccine, EGF/EGFR binding inhibition, Epidermal growth factor, immunotherapy, lung cancerAutores:González G., Lage Davila A., Rodríguez G., Tania CrombetFuentes:scopus